Abstract
Ticlopidine hydrochloride (TH), a potent inhibitor of platelet aggregation, is widely used for stroke prophylaxis. [1] Neutropenia is a relatively common side effect, and appropriate precautions and recommendations for hematologic monitoring are recommended in the dispensing literature. [2] We report a case of aplastic anemia that developed within 5 weeks of initiation of TH therapy. ### Case report. Our patient was an 80-year-old woman with a history of cerebrovascular …
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Paper version not known
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
